12:00 AM
 | 
Mar 18, 2002
 |  BioCentury  |  Politics, Policy & Law

Medicare cancer drug carve out; German scientists not satisfied

While efforts to enact a Medicare prescription drug benefit have stalled, prospects for passage this year of legislation that would extend Medicare coverage to include oral cancer therapies are much better.

Under current law, Medicare only reimburses for drugs and biologics that are injectable and administered during a visit to a doctor, or those that are an oral form of an injectable drug. Legislation that would extend Medicare coverage to all FDA approved drugs used to treat cancer - on- or off-label - has received bipartisan support. As of Friday, 34 senators had signed on to sponsor the Access to Cancer Therapies Act (S. 913) and 247 representatives had committed...

Read the full 535 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >